AN2 Therapeutics
0 followers
ANTX
Performance
About AN2 Therapeutics
AN2 Therapeutics develops novel therapeutics using a boron chemistry platform to target rare, chronic, and serious infectious diseases, with potential applications in oncology. The company emphasizes first-in-class targets and has a pipeline of boron-based compounds aimed at infectious diseases and cancer, with research and development activities centered in the United States. AN2 positions itself as experienced industry leaders focused on advancing human health in areas of high unmet medical need. Headquartered in Menlo Park, California, the company engages in drug discovery and development across its technology, pipeline, and collaborations.
Recent News
No recent news for this company.